A Study of Single and Multiple Oral Doses of TollB-001

Clinical trial NCT06103773 · UNKNOWN

Trial details

NCT number: NCT06103773
Sponsor: Toll Biotech Co. Ltd. (Beijing)
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2023-09-28
Primary completion: 2024-06-09
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.